US3869349A - Method for the enzymatic hydrolysis of cholesterol esters - Google Patents
Method for the enzymatic hydrolysis of cholesterol esters Download PDFInfo
- Publication number
- US3869349A US3869349A US454659A US45465974A US3869349A US 3869349 A US3869349 A US 3869349A US 454659 A US454659 A US 454659A US 45465974 A US45465974 A US 45465974A US 3869349 A US3869349 A US 3869349A
- Authority
- US
- United States
- Prior art keywords
- lipase
- cholesterol
- protease
- improved method
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 51
- 150000001840 cholesterol esters Chemical class 0.000 title claims abstract description 24
- 230000007071 enzymatic hydrolysis Effects 0.000 title description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 title description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 106
- 102000004882 Lipase Human genes 0.000 claims abstract description 69
- 108090001060 Lipase Proteins 0.000 claims abstract description 69
- 239000004367 Lipase Substances 0.000 claims abstract description 69
- 235000019421 lipase Nutrition 0.000 claims abstract description 68
- 239000004365 Protease Substances 0.000 claims abstract description 65
- 108091005804 Peptidases Proteins 0.000 claims abstract description 50
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 50
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 39
- 230000000694 effects Effects 0.000 claims abstract description 39
- 239000000203 mixture Substances 0.000 claims abstract description 20
- 102000000019 Sterol Esterase Human genes 0.000 claims abstract description 16
- 108010055297 Sterol Esterase Proteins 0.000 claims abstract description 16
- 230000007062 hydrolysis Effects 0.000 claims abstract description 14
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 14
- 210000002966 serum Anatomy 0.000 claims description 42
- 235000019419 proteases Nutrition 0.000 claims description 37
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 108090000371 Esterases Proteins 0.000 claims description 10
- NAACPBBQTFFYQB-UHFFFAOYSA-N Linolsaeure-cholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCC=CCCCCC)C2 NAACPBBQTFFYQB-UHFFFAOYSA-N 0.000 claims description 8
- NAACPBBQTFFYQB-XNTGVSEISA-N cholesteryl octadeca-9,12-dienoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCC=CCC=CCCCCC)C1 NAACPBBQTFFYQB-XNTGVSEISA-N 0.000 claims description 8
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 7
- 108090000526 Papain Proteins 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 235000019834 papain Nutrition 0.000 claims description 7
- 229940055729 papain Drugs 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 240000006439 Aspergillus oryzae Species 0.000 claims description 6
- 108010004032 Bromelains Proteins 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 235000019835 bromelain Nutrition 0.000 claims description 6
- 241000209140 Triticum Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 108010079522 solysime Proteins 0.000 claims description 5
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 4
- 108050006759 Pancreatic lipases Proteins 0.000 claims description 4
- 102000019280 Pancreatic lipases Human genes 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
- 244000063299 Bacillus subtilis Species 0.000 claims description 2
- 241000187392 Streptomyces griseus Species 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 108010027597 alpha-chymotrypsin Proteins 0.000 claims 1
- 238000001030 gas--liquid chromatography Methods 0.000 abstract description 7
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 6
- 238000006911 enzymatic reaction Methods 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 229940088598 enzyme Drugs 0.000 description 16
- 102000035195 Peptidases Human genes 0.000 description 11
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- CFYIUBWVKZQDOG-UHFFFAOYSA-N 4-[[2-[[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(NC(=O)CNC(=O)CNC(=O)CCC(=O)O)CC1=CC=CC=C1 CFYIUBWVKZQDOG-UHFFFAOYSA-N 0.000 description 9
- 238000003556 assay Methods 0.000 description 8
- ZYURHZPYMFLWSH-UHFFFAOYSA-N octacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC ZYURHZPYMFLWSH-UHFFFAOYSA-N 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 5
- 108010089254 Cholesterol oxidase Proteins 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 108010059712 Pronase Proteins 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000007824 enzymatic assay Methods 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000005051 trimethylchlorosilane Substances 0.000 description 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 238000008620 Cholesterol Assay Methods 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000303962 Rhizopus delemar Species 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- -1 elastas Proteins 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 108091016642 steapsin Proteins 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XCOBLONWWXQEBS-UHFFFAOYSA-N trimethylsilyl 2,2,2-trifluoro-n-trimethylsilylethanimidate Chemical compound C[Si](C)(C)OC(C(F)(F)F)=N[Si](C)(C)C XCOBLONWWXQEBS-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/832—Bacillus
- Y10S435/839—Bacillus subtilis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
- Y10S435/897—Streptomyces griseus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/913—Aspergillus
- Y10S435/918—Aspergillus oryzae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/921—Candida
Definitions
- ABSTRACT A totally enzymatic method for the hydrolysis of cholesterol esters using a lipase having cholesterol esterase activity and a protease and a method for quantitative determination of total cholesterol in compositions containing both free and esterified cholesterol comprising enzymatically hydrolyzing the cholesterol esters with a lipase having cholesterol esterase activity and a protease and determining total cholesterol by gas-liquid chromatography or :some other suitable technique are described.
- This invention relates to an enzymatic method for hydrolyzing cholesterol esters in complex aqueous solutions which may contain both free and esterified cholesterol, for example, blood serum and in particular to a process comprising enzymatically hydrolyzing cholesterol esters using a lipase having cholesterol esterase activity and a protease.
- hydrolysis of cholesterol esters in complex aqueous solutions is achieved by treating the blood serum with a mixture comprising per ml of serum from about 20 to about 50 mg 'of a lipase having cholesterol ester ase activity and from about 5 to about mg of a protease at a temperature of from about 25 to about C and a pH of from about 6.5 to about 9.5 for about 5 to about 15 minutes, preferably with agitation and in an inert atmosphere.
- the lipase should containat least about 30 international units per mg and the protease at least about 10 units per mg.
- One unit of lipase is defined as the amount of the enzyme which will liberate 1 micro mole of fatty acid in a given time at a given pH and temperature using a substrate containing esterified fatty acid.
- the conditions are 1 minute at pH 7 and 37C with olive oil as substrate.
- protease hydrolyze casein to produce color equivalent to 1 micro mole (181 ug) tyrosine per minute at pH 7.5 and a temperature of 37C. (Color per Folin-Ciocalteu Reagent). It should, of course, be clear that as the level of enzyme activity per unit by weight of preparation increases or decreases, so also will the quantity of'enzyme preparation added vary. Most preferably, the ratio of lipase to protease on an activity basis should range from about 3 to about 10 and at least about I000 units of lipase should be used per ml of serum. Relative lipase activity to esteraseactivity is usually about 10 to about 50.
- aqueous medium containing the cholesterol ester preferably blood serum, which contains both esterified and free cholesterol
- a lipase which demonstrates cholesterol esterase activity as defined in Example 3 and a protease.
- the lipase maybe of plant or animal origin, but we prefer and find best a microbial lipase such as the lipase from'Cana'ida cylindracca. Lipasesfrom Chronzobacterium viscosum, variant paralipolyticum, crude or purified, the lipase from Rhizopus delemar, purified, for example as noted in Fukumoto et al, J. Gen. Appli.
- lipases having similar activity which are those described in the aforementioned Bucolo and Davis publication, do not demonstrate the required cholesterol esterase activity.
- Specifically preferred commercial lipase preparations include wheat germ lipase supplied by Miles Laboratories of Elkhart, Ind.,
- Proteases in general may be used in the successful practice of this invention. These include by way of example, chymotrypsin, Strepromyces griseus protease (commercially available under the registered trademark Pronase), Aspergillus oryzae protease, Bacillus subtilis protease, elastas, papain and bromelain. Mixtures of such enzymes, of course, may also be emtein containing solution the most notable and important of which is, of course, blood serum. In the case where a simple non protenaceous solution is being assayed, it is possible, as demonstrated in Example 3 below, to obtain ester hydrolysis using only the lipase. As also demonstrated by the Examples, however, in a protein containing solution such as serum, the presence of the protease is essential to useful results.
- the free cholesterol liberated by'the action of the foregoing enzyme mixture may be assayed in a number of ways. According to a preferred embodiment of the instant invention, this assay is performed using gas-liquid chromatography.
- an aliquot generally from about 0.5 to about 5 ml of the hydrolyzed aqueous composition to be tested, hereinafter blood serum, is mixed with from about 0.5 to about 2 ml of heptane or some other suitable organic solvent, for example, isooctane, containing from about 25 mg to about 50 mg weight percent octacosane or some other organic suitable for use as an internal standard.
- heptane may, of course, be replaced with any other solvents suitable for gas-liquid chromatography, for example, isooctane.
- the solvent mixture is then extracted with water according to conventional techniques, preferably using from about 3 to about ml of water per ml of solvent solution.
- the water extracted solvent solution is then reacted with a silylating agent, for example, (N,O-bis(- trimethylsilyl) trifluoroacetanide with 1% trimethylchlorosilane or a mixture of equal volumes of trimethylchlorosilane and 1,1,1,3,3,3,-hexamethyldisilazane for a period of from about 2 to about minutes.
- a silylating agent for example, (N,O-bis(- trimethylsilyl) trifluoroacetanide with 1% trimethylchlorosilane or a mixture of equal volumes of trimethylchlorosilane and 1,1,1,3,3,3,-hexamethyldisilazane for a period of from about 2 to about minutes.
- the silylated solvent solution is then passed through a conventional gas-liquid chromatograph to determine the total cholesterol in the sample under examination. This method for determining cholesterol concentration is an adaptation of the technique described in detail in J. L. Driscoll, D. Au
- Validate a reconstituted serum standard produced by the Warner-Lambert Company, was used in the examples below.
- the total cholesterol content of Validate (lot 2560121) was checked by saponifying an aliquot according to the method of Driscoll et a1, and analyzing the heptane extract by both glc and the Liebermann-Burchard method. Values of 160 and 162 mg% respectively were obtained. These are well within the range of values quoted by the supplier 148-192 mg%).
- the hydrolysis is performed in an atmosphere of nitrogen in order to minimize artifacts introduced by autooxidation of cholesterol and its esters; of course, proper correction for such autooxidation factors will permit hydrolysis to be performed in a normal atmosphere.
- EXAMPLE 1 EXAMPLE 2 QUANTITATIVE ESTIMATION OF TOTAL CHOLESTEROL BY GAS-LIQUID CHROMATOGRAPHY (GLC)
- serum or reconstituted serum standards containing up to 150 mg% cholesterol are mixed with 5 ml ethanol and shaken 3 minutes with 1 ml heptane containing 50 mg7c octacosane.
- Five ml of water is added and the mixture is shaken again for 3 minutes.
- the layers separate equal portions of the heptane layer and N,O-bis(trimethylsilyl) trifluoroacetamide with 1% trimethylchlorosilane are mixed.
- reaction 1 ul samples are injected into a Hewlett Packard F and M 810 chromatograph with a single stainless steel column (l/8 inch X 4 feet) packed with 3% SE30 on 0v 1.
- Gas flow rate 20 ml/min, oven temperature 250C, injection pop 260C, flame detector 265C, range 10 attenuation X l, chart speed k inch/min.
- Octacosane retention time is about 1 min.
- Cholesterol retention time is about 2% min. Runs are complete in about 4 min. Under these conditions the amount of cholesterol in the sample is proportional to the peak height ratios of cholesterol to octacosane. This method is adapted from Driscoll et a1 referred to above.
- EXAMPLE 5 ESTERASE ACTIVITY OF LIPASE-PROTEASE COMBINATIONS ON SERUM CHOLESTEROL ESTERS Combinations of Lipase M and various proteases were tested in the same manner as in Example 4. Proteases, except for a-chymotrypsin, were added directly to serum at 40 mg per ml; a-chymotrypsin was added at 8 mg per ml. The amount of cholesterol (mg%) released by each combination is shown in Table III.
- Lipase M to be optimally effective on serum cholesterol esters, a protease must also be present.
- EXAMPLE 6 A series of commercially prepared proteases were tested for their ability to enhance esterase activity of Lipase M in serum. Protease was added directly to serum in the amounts shown in Table IV. Lipase M concentration was 40 mg per ml serum. Otherwise assay and conditions are the same as in Example 4. The results are contained in Table IV.
- Lipase M 36 All of the proteases tested appear to enhance the activity ofLipase M somewhat more than a-chymotrypsin and papain. However, it is difficult: to compare the activities of these proteases on the basis of units given by suppliers since several different assays are used. In general, the enzymes judged less pure were used in the higher amounts.
- EXAMPLE 7 Four different buffers were tested in a system containing three enzymes. Each sample consists of I ml Validate," 40 mg Lipase M. 40 mg papain, 8 mg a-chymotrypsin and 0.I M buffer to 3 ml total volume. The mixtures were incubated and tested as in Example 4. The results are depicted in FIG. I.
- EXAMPLE 8 Studies with tris buffer were conducted on combinations of Lipase M with the series of proteases described in Example 6. The amount of each protease used was that which gave the best result in the experiment shown in Table IV. Three pH values between 7 and 9 were tested. The assay was the same as described in Example Most of these proteases show an optimum within the three values tested. The best results were obtained with 6 except that time was reduced to 5 minutes so that it bromelain at pH 8.1, Calbiochem bacterial protease at pH values from 8 to 9, A. oryzae protease at pH 8.1 and a-chymotrypsin at pH 7.2.
- Each incubation mixture contained 0.5 ml Validate, 0.5 ml 0.2M tris buffer at pH shown, mg 1ipase M and the protease in the amounts shown. lncubation was for 5 minutes under N at C, 250 rpm. Samples were analyzed by glc as in Example 2. The results are indicated in Table V.
- any ofthe well known conventional techniques for the analysis of total free cholesterol may be used. These include the Pearson, Stern and McGarack, Carr and Drecker, and Zak methods described at pages 355-361 of Fundamentals of Clinical Chemistry, Tl- ETZ, N. W., W. B. SAUNDERS CO. (1970) as well as the well known Lieberman-Burchard technique and the cholesterol oxidase method described in German Offenlegungschrifft No.
- aqueous liquid is serum and said treating step is accomplished with a mixture comprising from about 600 to about 1500 units of said lipase having cholesterol ester- 10 ase activity and from about 50 to about 500 units of said protease per ml of serum.
- said lipase is selected from the group consisting of wheat germ lipase, pancreatic lipases and the lipase from Candida cylindracca.
- protease is selected from the group consisting of a-chymotrypsin, papain, bromelain, Bacillus subll'lis protease, Aspergillus oryzae protease, Streptomyces griseus protease and mixtures thereof.
- said lipase is selected from the group consisting of wheat germ lipase, pancreatic lipases and the lipase from Candida cylindracca.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US454659A US3869349A (en) | 1974-03-25 | 1974-03-25 | Method for the enzymatic hydrolysis of cholesterol esters |
| CA220,426A CA1046389A (en) | 1974-03-25 | 1975-02-19 | Method for the enzymatic hydrolysis of chlolesterol esters |
| DE19752512605 DE2512605B2 (de) | 1974-03-25 | 1975-03-21 | Verfahren zur bestimmung des gesamt- cholesteringehaltes waessriger fluessigkeiten |
| GB12202/75A GB1498461A (en) | 1974-03-25 | 1975-03-24 | Quantitative determination of cholesterol |
| JP3504475A JPS5615240B2 (online.php) | 1974-03-25 | 1975-03-25 | |
| FR7509199A FR2265759B1 (online.php) | 1974-03-25 | 1975-03-25 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US454659A US3869349A (en) | 1974-03-25 | 1974-03-25 | Method for the enzymatic hydrolysis of cholesterol esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3869349A true US3869349A (en) | 1975-03-04 |
Family
ID=23805542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US454659A Expired - Lifetime US3869349A (en) | 1974-03-25 | 1974-03-25 | Method for the enzymatic hydrolysis of cholesterol esters |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3869349A (online.php) |
| JP (1) | JPS5615240B2 (online.php) |
| CA (1) | CA1046389A (online.php) |
| DE (1) | DE2512605B2 (online.php) |
| FR (1) | FR2265759B1 (online.php) |
| GB (1) | GB1498461A (online.php) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4011045A (en) * | 1975-02-14 | 1977-03-08 | Bonderman Dean P | Turbidity reduction in triglyceride standards |
| US4011138A (en) * | 1974-06-17 | 1977-03-08 | Kyowa Hakko Kogyo Co., Ltd. | Process for the preparation of cholesterol esterase |
| EP0019253A1 (en) * | 1979-05-21 | 1980-11-26 | Miles Laboratories, Inc. | Test device, composition and method for the determination of triglycerides |
| US4275151A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
| US4275152A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
| US4680259A (en) * | 1984-09-26 | 1987-07-14 | Eastman Kodak Company | Analytical element and method for colorimetric determination of total cholesterol |
| US5116741A (en) * | 1988-04-12 | 1992-05-26 | Genex Corporation | Biosynthetic uses of thermostable proteases |
| US5219733A (en) * | 1985-03-06 | 1993-06-15 | Yoshikawa Oil & Fat Co., Ltd. | Process for preparing fatty acid esters |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112877219A (zh) * | 2021-01-29 | 2021-06-01 | 江西科技师范大学 | 一种高浓度胆固醇培养基及其制备方法和应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2224132A1 (online.php) * | 1972-05-17 | 1973-11-22 |
-
1974
- 1974-03-25 US US454659A patent/US3869349A/en not_active Expired - Lifetime
-
1975
- 1975-02-19 CA CA220,426A patent/CA1046389A/en not_active Expired
- 1975-03-21 DE DE19752512605 patent/DE2512605B2/de not_active Withdrawn
- 1975-03-24 GB GB12202/75A patent/GB1498461A/en not_active Expired
- 1975-03-25 FR FR7509199A patent/FR2265759B1/fr not_active Expired
- 1975-03-25 JP JP3504475A patent/JPS5615240B2/ja not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2224132A1 (online.php) * | 1972-05-17 | 1973-11-22 |
Non-Patent Citations (1)
| Title |
|---|
| J. Hyun et al., " The J. of Biol. Chem.," 244, No. 7, pp 1937-1945, 1969. * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4011138A (en) * | 1974-06-17 | 1977-03-08 | Kyowa Hakko Kogyo Co., Ltd. | Process for the preparation of cholesterol esterase |
| US4011045A (en) * | 1975-02-14 | 1977-03-08 | Bonderman Dean P | Turbidity reduction in triglyceride standards |
| US4275151A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
| US4275152A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
| EP0019253A1 (en) * | 1979-05-21 | 1980-11-26 | Miles Laboratories, Inc. | Test device, composition and method for the determination of triglycerides |
| US4680259A (en) * | 1984-09-26 | 1987-07-14 | Eastman Kodak Company | Analytical element and method for colorimetric determination of total cholesterol |
| US5219733A (en) * | 1985-03-06 | 1993-06-15 | Yoshikawa Oil & Fat Co., Ltd. | Process for preparing fatty acid esters |
| US5116741A (en) * | 1988-04-12 | 1992-05-26 | Genex Corporation | Biosynthetic uses of thermostable proteases |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2512605B2 (de) | 1976-11-18 |
| GB1498461A (en) | 1978-01-18 |
| CA1046389A (en) | 1979-01-16 |
| JPS50131588A (online.php) | 1975-10-17 |
| FR2265759B1 (online.php) | 1977-11-25 |
| DE2512605A1 (de) | 1975-10-02 |
| JPS5615240B2 (online.php) | 1981-04-09 |
| FR2265759A1 (online.php) | 1975-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Toshihide et al. | A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity | |
| Shimizu et al. | Enzymatic microdetermination of serum free fatty acids | |
| Allain et al. | Enzymatic determination of total serum cholesterol | |
| Bucolo et al. | Quantitative determination of serum triglycerides by the use of enzymes | |
| Thomson et al. | Detection and measurement of microbial lipase activity: a review | |
| US4275152A (en) | Hydrolysis of protein-bound cholesterol esters | |
| CA1143637A (en) | Hydrolysis and assay of triglycerides | |
| JPS63126498A (ja) | Hdl−フラクションのコレステリンの特異的測定法及び測定試薬 | |
| US3884764A (en) | Method and composition for blood serum cholesterol analysis | |
| US3898130A (en) | Rapid enzymatic hydrolysis of triglycerides | |
| Doi et al. | Lysophospholipase of Escherichia coli. | |
| Humbert et al. | Method for the measurement of lipase activity in milk | |
| CA1046389A (en) | Method for the enzymatic hydrolysis of chlolesterol esters | |
| US4394445A (en) | Enzymatic glyceride hydrolysis | |
| Fossati et al. | Kinetic colorimetric assay of lipase in serum | |
| JPS5948098A (ja) | リパ−ゼの測定方法 | |
| US4045297A (en) | Triglycerides determination method | |
| Patel et al. | Characterization of Leptospiral lipase | |
| CA1198040A (en) | Stabilized enzymatic solutions and methods for determining total cholesterol in human serum | |
| CA1321945C (en) | Test composition and method for the determination of anilides | |
| US4275151A (en) | Hydrolysis of protein-bound cholesterol esters | |
| GB1590736A (en) | Chemical assay method | |
| US4347313A (en) | Analytical determination of lipase | |
| Festenstein | Substrates for rumen β-glucosidase | |
| Renard et al. | An improved method for the colorimetric assay of lipase activity using an optically clear medium |